Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fong

Showing results (401-410 of 468) with videos related to

Pageof 47
Sort By:
The Lancet. Oncology|February 22, 2015
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trialFred Saad, Karim Fizazi, Viorel Jinga, et al.
Nature Communications|April 26, 2022
Machine learning-coupled combinatorial mutagenesis enables resource-efficient engineering of CRISPR-Cas9 genome editor activitiesDawn G L Thean, Hoi Yee Chu, John H C Fong, et al.
Molecular Genetics and Metabolism|March 1, 2015
Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelinesB H Vogel, S E Bradley, D J Adams, et al.
Future Oncology (London, England)|February 5, 2014
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancerL Rhoda Molife, Aurelius Omlin, Rob J Jones, et al.
Psychosomatic Medicine|October 6, 2022
Epigenome-Wide Analysis of DNA Methylation and Optimism in Women and MenCuicui Wang, Dawn L DeMeo, Eric S Kim, et al.
European Urology Oncology|May 3, 2026
Pembrolizumab Plus Lenvatinib in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort EMarinela Augustin, Brigitte Laguerre, Capucine Baldini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free intervalPeter C Fong, Timothy A Yap, David S Boss, et al.
British Journal of Cancer|July 15, 2010
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label studyL R Molife, P C Fong, L Paccagnella, et al.
JAMA Neurology|December 21, 2019
Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal DementiaAndy J Liu, Adam M Staffaroni, Julio C Rojas-Martinez, et al.
European Urology Focus|August 12, 2025
Vibostolimab Coformulated with Pembrolizumab in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: KEYNOTE-365 Cohort GPeter C Fong, Mariusz Kwiatkowski, Alessandra Mosca, et al.
Pageof 47

Showing results (401-410 of 468) with videos related to

Sort By:
Pageof 47
The Lancet. Oncology|February 22, 2015
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trialFred Saad, Karim Fizazi, Viorel Jinga, et al.
Nature Communications|April 26, 2022
Machine learning-coupled combinatorial mutagenesis enables resource-efficient engineering of CRISPR-Cas9 genome editor activitiesDawn G L Thean, Hoi Yee Chu, John H C Fong, et al.
Molecular Genetics and Metabolism|March 1, 2015
Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelinesB H Vogel, S E Bradley, D J Adams, et al.
Future Oncology (London, England)|February 5, 2014
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancerL Rhoda Molife, Aurelius Omlin, Rob J Jones, et al.
Psychosomatic Medicine|October 6, 2022
Epigenome-Wide Analysis of DNA Methylation and Optimism in Women and MenCuicui Wang, Dawn L DeMeo, Eric S Kim, et al.
European Urology Oncology|May 3, 2026
Pembrolizumab Plus Lenvatinib in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort EMarinela Augustin, Brigitte Laguerre, Capucine Baldini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free intervalPeter C Fong, Timothy A Yap, David S Boss, et al.
British Journal of Cancer|July 15, 2010
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label studyL R Molife, P C Fong, L Paccagnella, et al.
JAMA Neurology|December 21, 2019
Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal DementiaAndy J Liu, Adam M Staffaroni, Julio C Rojas-Martinez, et al.
European Urology Focus|August 12, 2025
Vibostolimab Coformulated with Pembrolizumab in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: KEYNOTE-365 Cohort GPeter C Fong, Mariusz Kwiatkowski, Alessandra Mosca, et al.
Pageof 47